Titre original:
A phase 1b, randomized, double-blind, placebo-controlled, multi-center, single-ascending dose study to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of DS-1040b when added to standard of care anticoagulation therapy in subjects with acute submassive pulmonary embolism
Indication (pathologie):
Embolie pulmonaire
Identifiant SNOMED-CT:
SCTID: 59282003
Identifiant EUDRA-CT:
2015-005211-32
Phase de l'étude:
Phase II
Recrutement:
Ouvert
Service:
Investigateur principal:
Wautrecht Jean-Claude
Sponsor:
Daiichi Sankyo
Tél contact:
02 555 43 95
Email contact:
Adresse hôpital:
Cliniques Universitaires de Bruxelles Hôpital Erasme
Route de Lennik 808,1070 Bruxelles, Belgique